首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Canadian liver journal

缩写:

ISSN:N/A

e-ISSN:2561-4444

IF/分区:1.2/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引281
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Vikrant Sood,Bikrant B Lal,Aniket Deshmukh et al. Vikrant Sood et al.
Background: Non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease in children. Its prevalence is rising globally, yet it is...
Christian Vincelette,Philémon Mulongo,Jeanne-Marie Giard et al. Christian Vincelette et al.
Background: Liver transplant (LT) is the definitive treatment for end-stage liver disease. Limited resources and important post-operative implications for recipients compel judicious risk stratification and patient select...
Gabrielle Jutras,Genevieve Huard,Marc Bilodeau et al. Gabrielle Jutras et al.
Background: The surge of end-stage liver disease among older individuals challenges traditional age-based criteria for liver transplantation (LT), historically capped at 65 years. Our Canadian center shifted away from usi...
Cindy Whitten,Alison Turner,Kobe Roberts et al. Cindy Whitten et al.
Background: Global elimination of hepatitis C virus (HCV) is feasible using existent tools. Reporting the provincial HCV care cascade will contribute to national and global HCV elimination efforts. ...
Julian Hercun,Golasa Samadi Kochaksaraei,Simmone D&#x;souza et al. Julian Hercun et al.
Hepatitis B virus (HBV) infection affects >290 million people worldwide, including ∼250,000 Canadians, and it stands as a leading cause of end-stage liver disease and liver cancer. The World Health Assembly has set goals for HBV eliminatio...
Marjan Naghshbandi,Simon Y Huang,Hemant Shah et al. Marjan Naghshbandi et al.
Background: We evaluated an outpatient, nurse practitioner-led transitional care program with respect to its efficacy in reducing unplanned readmission rates for patients with liver disease. ...
Paul Mundra,Zeena Kailani,Mohammad Yaghoobi et al. Paul Mundra et al.
Background: Post-acute COVID-19 syndrome (PACS; long COVID) is characterized by persistent or delayed symptoms at least 4 weeks from acute COVID-19 infection. Given the well-documented incidence of liver injury in acute C...
Monica Dahiya,Michael Minkley,Daniel R Owen et al. Monica Dahiya et al.
Early acute cellular rejection occurs commonly within the first month after liver transplantation, is easily reversible with treatment, and has little impact on long-term graft survival. In contrast, late allograft rejection, typically defi...